Clinical Trials Browser

patritumab × Sarcoma × Clear all

NCT01042379 2026-05-06

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT01479023 2013-12-20

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

Phase 1 Terminated

LymphoidSarcoma

Carcinoma, Lymphoma, Sarcoma